Martínez-Tapia AL, Robles-Pérez E, Jiménez-Hernández A, Ramos-Cano VH

Language: Spanish
References: 35
Page: 60-67
PDF size: 284.56 Kb.

ABSTRACT

Aortic aneurysms represent the most frequent injury and life-threatening disease of the thoracic aorta. They have different etiologic factors nevertheless it has been seen a clear association with bicuspid aortic valve. Certain genes have been identified as responsible for causing aneurysms such as NOTCH1, UFDL1, ACTA2, eNOS among others, which increase significantly the risk of onset complications such as aortic dissection and subsequent rupture, causing death to the patient at a rate close to 100%. It is suggested a dominant autosomal pattern for isolated cases. A successful case of a 55 year old male is presented, who enters the hospital with ruptured aneurysm and aortic dissection that manifested as severe aortic insufficiency with hemodynamic instability and cardiac tamponade, for which surgical treatment was elected the Bentall and De Bonno procedure. Evolving satisfactorily, the patient is currently alive and without any impact on his daily activities. Therefore, it is important an early diagnosis as well as concurrence and synchrony of an interdisciplinary team in the detection, treatment and subsequent medical attention to the survival of the life-threatening disease in patients.

REFERENCES

1. Hiratzka L, Bakris G, Beckman J, et al. 2010 ACCF/AHA/ AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation 2010; 121: e266-e369.

2. Braverman A. Acute aortic dissection: clinician update. Circulation 2010; 122: 184-8.

3. Olsson C, Thelin S, Stahle E, et al. Thoracic aortic aneurysm and dissection: increasing prevalence and improves outcomes reported in nationwide population-based study of more than 14,000 cases from 1987 to 2002. Circulation 2006; 114: 2611-8.

4. Tadros T, Klein M, Shapira O. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation 2010; 119: 880-90.

5. Michelena H, Khanna A, Mahoney D, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA 2011; 306: 1004-113.

6. Ehrlich M, Arisan M, McCullough J, et al. Results of immediate surgical treatment of all acute type a dissections. Circulation 2000; 102: Iii-248-Iii-252.

7. Wolfgang H, Pethig K, Hagl C, et al. Ascending aortic replacement with aortic valve reimplantation. Circulation 1999; 100: II-24-Ii-28.

8. Tsai T, Nienaber A, Eagle. Acute aortic syndromes. Circulation 2005; 112: 3802-13.

9. Davies R, Kaple R, Mandapati D, et al. Natural history of ascending aortic aneurysms in the setting of an unreplaced bicuspid aortic valve. Ann Thorac Surg 2007; 83: 1338-44.

10. Nienaber C, Eagle K. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation 2003; 108: 628-35.

11. Nkomo V, Enriquez-Serrano M, Ammash N, et al. Bicuspid aortic valve associated with aortic dilatation: a communitybased study. arterioescler Thromb Vasc Biol 2003; 23: 351-6.

12. Bonderman D, Gharehbaghi-Schnell E, Wollenek G, et al. Mechanisms underlying aortic dilatation in congenital aortic valve malformation. Circulation 1999; 99: 2138-43.

13. Fedak P, Verma S, David T, et al. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002; 106: 900-4.

14. Robinson P, Godfrey M. The molecular genetics of Marfan syndrome and related microfibrillinopathies. J Biol Chem 2010; 34: 9-18.

15. Martin L, Ramachandran V, Cripe L, et al. Evidence in favor of linkage to human chromosomal regions 18q, 5q, 13q for bicuspid aortic valve and associated cardiovascular malformations. Hum Genet 2007; 121: 275-84.

16. Nishigami K, Tsuchiya T, Shono H. Disappearance of aortic intramural hematoma and its significance to the prognosis. Circulation 2000; 102: Iii-243-Iii-247.

17. Ikonomidis J, Jones J, Stroud R, et al. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Urg 2007; 133: 1028-36.

18. Boyum J, Fellinger E, Schmoker J, et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 2004; 127: 686-91.

19. Hagan P, Nienaber C, Isselbacher E, et al. The International Registry of Acute Aortic Dissection (IRAD). JAMA 2000; 283: 897-903.

20. Warren A, Boyd O’Connell C, et al. Dilatation of the Ascending aorta in paediatric patients with bicuspid aortic valve: frequency, rate of progression and risk factors. Heart 2006; 92: 1496-500.

21. Mohamed S, Hanke T, Schlueter C, et al. Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve. J Thorac Cardiovasc Surg 2005; 130: 1531-6.

22. Nienaber C, Spielmann R, von Kodolitsch, et al. Diagnosis of thoracic aortic dissection. Magnetic resonance imaging versus transesophageal echocardiography. Circulation 1992; 85: 434-47.

23. Ausoni S, Sartore S. Cell lineages and tissue boundaries in cardiac arterial and venous poles: developmental patterns, animal models and implications for congenital vascular diseases. Arterioescler Thromb Vasc Biol 2001; 21: 312-20.

24. Tomaschütz L, Dos Santos M, Schill J, Grau A. Recurrent amaurosis fugax in a patient after stanford type a dissection depending on blood pressure and haemogobin level. Vascular Medicine 2012; 10(1155): 1-4.

25. Zehr K, Orszulak A, Mullany C, et al. Surgery for Aneurysms of the Aortic Root: A 30-year Experience. Circulation 2004; 110: 1364-71.

26. Elefteriades J. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. Ann Thorac Surg 2002; 74: 1877-80.

27. Milewicz D. Stopping a killer: improving the diagnosis, treatment, and prevention of acute ascending aortic dissections. Circulation 2011; 124: 1902-4.

28. Matthias E, Costin N, Allaire E. Pathobiology of Idiopathic Ascending Aortic Aneurysms. Asian Cardiovasc Thorac Ann 2006; 14: 254-60.

29. Ihling C, Szombathy T, Nampoothiri K, Haendeler J, Beyersdorf F, Uhl M, et al. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart 1999; 82: 286-93.

30. Belz GG. Elastic properties and Windkessel function of the human aorta. Cardiovasc Drugs Ther 1995; 9: 73-83.

31. Boyum J, Fellinger EK, Schmoker JD, Trombley L, McPartland K, Ittleman FP, et al. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. J Thorac Cardiovasc Surg 2004; 127: 686-91.

32. Yacoub MH, Kilner PJ, Birks EJ, Misfeld M. The aortic outflow and root: a tale of dynamism and crosstalk. Ann Thorac Surg 1999; 68(3 Suppl.): S37-S43.

33. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue array matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004; 78: 2106-11.

34. Schlatmann TJ, Becker AE. Histological changes in the normal aging aorta: implications for dissecting aortic aneurysm. Am J Cardiol 1977; 39: 13-20.

35. Fedak PW, Verma S, David TE, Leask RL, Weisel RD, Butany J. Clinical and pathophysiological implications of a bicuspid aortic valve. Circulation 2002; 106: 900-4.